Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
Oliver Bredemeyer1, Salil Patel1, James J FitzGerald1,2,3
1NeuroMetrology Group, Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
Frontiers in Digital Health
|August 22, 2022
Summary
Parkinson's disease (PD) impairs eye movements, specifically increasing reaction time and altering movement damping in a task-dependent manner. Saccadometry shows potential for quantifying neurological dysfunction in PD.
Area of Science:
- Neurology
- Ophthalmology
- Biomedical Engineering
Background:
- Parkinson's disease (PD) impacts motor and cognitive functions.
- Saccadic eye movements offer objective, non-invasive measures of neurological function.
- Saccadometry is a promising tool for assessing movement disorders.
Purpose of the Study:
- To evaluate saccadic eye movement characteristics (latency, damping, amplitude) in Parkinson's disease patients.
- To investigate the impact of PD on motor and cognitive aspects of saccades.
- To develop a model for inferring disease status using saccadometry data.
Main Methods:
- Pilot study involving 25 PD patients and 26 healthy controls.
- Measurement of saccadic eye movement latency, damping, and amplitude during two tasks.
- Analysis of task-dependent saccadic damping and reaction time.
- Development of a proof-of-concept multivariate model.
Main Results:
- Parkinson's disease patients exhibited increased saccadic reaction time.
- Saccadic damping was found to be task-dependent and significantly affected by PD.
- The study demonstrated the feasibility of combining saccadometry metrics.
Conclusions:
- Saccadometry is a sensitive tool for detecting motor and cognitive impairments in Parkinson's disease.
- Task-dependent changes in saccadic damping are a key indicator of PD.
- Multivariate analysis of saccadometry data can aid in inferring disease status.
Related Concept Videos
Parkinson's Disease: Overview
684
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
684
Parkinson's Disease: Treatment
361
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
361


